131 related articles for article (PubMed ID: 31020888)
1. New insights in the treatment of patients with solitary bone plasmacytoma.
Mheidly K; Lamy De La Chapelle T; Hunault M; Benboubker L; Benchalal M; Moreau P; Baugier de Materre A; Decaux O; Laribi K
Leuk Lymphoma; 2019 Nov; 60(11):2810-2813. PubMed ID: 31020888
[No Abstract] [Full Text] [Related]
2. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
3. [Solitary bone plasmacytoma: about 3 cases and review of the literature].
Masmoudi K; Elleuch E; Akrout R; Mnejja MA; Feki A; Ezzeddine M; Baklouti S; Jemaâ B
Pan Afr Med J; 2016; 25():219. PubMed ID: 28292172
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
5. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
6. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
7. Solitary plasmacytoma of bone: clinical features, treatment and survival.
Ellis PA; Colls BM
Hematol Oncol; 1992; 10(3-4):207-11. PubMed ID: 1398516
[TBL] [Abstract][Full Text] [Related]
8. The treatment of solitary plasmacytoma of bone and extramedullary plasmacytoma.
Greenberg P; Parker RG; Fu YS; Abemayor E
Am J Clin Oncol; 1987 Jun; 10(3):199-204. PubMed ID: 3591739
[TBL] [Abstract][Full Text] [Related]
9. Solitary plasmacytoma of jaw bone: a viewpoint on treatment modalities.
Choudhari S; Dhumal S; Mantri MJ; Gadbail A
Future Oncol; 2021 Jul; 17(19):2409-2412. PubMed ID: 34047196
[No Abstract] [Full Text] [Related]
10. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
11. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study.
Meis JM; Butler JJ; Osborne BM; Ordóñez NG
Cancer; 1987 Apr; 59(8):1475-85. PubMed ID: 3102035
[TBL] [Abstract][Full Text] [Related]
12. Seronegative arthritis in patient with solitary bone plasmacytoma.
Blach A; Zycinska-Debska E; Zon-Giebel A; Banas M; Kotulska A; Kucharz EJ
Clin Rheumatol; 2007 Jul; 26(7):1167-8. PubMed ID: 16609821
[TBL] [Abstract][Full Text] [Related]
13. Primary solitary extramedullary plasmacytoma progressing to multiple bone plasmacytomas: a rare condition with therapeutic dilemmas.
Suska A; Chmura Ł; Dyduch G; Małkowski B; Jurczyszyn A
Pol Arch Intern Med; 2018 Nov; 128(11):706-708. PubMed ID: 30335051
[No Abstract] [Full Text] [Related]
14. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
15. Solitary plasmacytoma of bone and soft tissues.
Tong D; Griffin TW; Laramore GE; Kurtz JM; Russell AH; Groudine MT; Herron T; Blasko JC; Tesh DW
Radiology; 1980 Apr; 135(1):195-8. PubMed ID: 7360960
[TBL] [Abstract][Full Text] [Related]
16. Solitary plasmacytoma of bone and soft tissues.
Mendenhall WM; Mendenhall CM; Mendenhall NP
Am J Otolaryngol; 2003; 24(6):395-9. PubMed ID: 14608572
[TBL] [Abstract][Full Text] [Related]
17. [Solitary bone plasmacytoma: experience of the National Institute of Oncology, Rabat (INO)].
Diakité A; Nouni K; Bellefqih S; Kebdani T; Benjaafar N
Pan Afr Med J; 2014; 17():180. PubMed ID: 25392726
[TBL] [Abstract][Full Text] [Related]
18. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
Soutar R; Lucraft H; Jackson G; Reece A; Bird J; Low E; Samson D; ; ;
Clin Oncol (R Coll Radiol); 2004 Sep; 16(6):405-13. PubMed ID: 15487132
[No Abstract] [Full Text] [Related]
19. Trends and outcomes of modern staging of solitary plasmacytoma of bone.
Warsame R; Gertz MA; Lacy MQ; Kyle RA; Buadi F; Dingli D; Greipp PR; Hayman SR; Kumar SK; Lust JA; Russell SJ; Witzig TE; Mikhael J; Leung N; Zeldenrust SR; Rajkumar SV; Dispenzieri A
Am J Hematol; 2012 Jul; 87(7):647-51. PubMed ID: 22549792
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
